Vernon K Sondak Selected Research

pyrazine-2-diazohydroxide (diazohydroxide)

2/2002

A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy--Southwest Oncology Group study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vernon K Sondak Research Topics

Disease

147	Melanoma (Melanoma, Malignant) 09/2022 - 01/2002
79	Neoplasms (Cancer) 09/2022 - 01/2002
33	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2002
9	Merkel Cell Carcinoma 01/2020 - 05/2002
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2012
6	Brain Neoplasms (Brain Tumor) 01/2018 - 01/2010
5	Sarcoma (Soft Tissue Sarcoma) 02/2012 - 04/2004
4	Skin Neoplasms (Skin Cancer) 01/2021 - 11/2008
4	Infections 01/2021 - 01/2016
4	Basal Cell Carcinoma (Rodent Ulcer) 01/2021 - 01/2011
3	Carcinoma (Carcinomatosis) 01/2021 - 05/2003
3	Papillomavirus Infections 01/2016 - 11/2008
2	COVID-19 01/2022 - 01/2021
2	Extranodal Extension 07/2021 - 06/2018
2	Uveal melanoma 11/2020 - 01/2012
2	Nausea 02/2015 - 10/2010
2	Anemia 02/2015 - 01/2005
2	Leukemia 11/2014 - 04/2004
2	Disease Progression 01/2012 - 05/2005
2	Diarrhea 10/2010 - 11/2008
1	Pneumonia (Pneumonitis) 01/2022
1	Exanthema (Rash) 01/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Hypoxia (Hypoxemia) 01/2019

Drug/Important Bio-Agent (IBA)

15	IpilimumabIBA 01/2022 - 11/2008
12	Biomarkers (Surrogate Marker)IBA 06/2022 - 09/2006
12	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2021 - 04/2009
12	InterferonsIBA 01/2021 - 01/2002
11	VaccinesIBA 10/2014 - 01/2002
10	VemurafenibIBA 11/2020 - 07/2011
9	Interleukin-2 (IL2)IBA 01/2022 - 06/2003
9	AntigensIBA 01/2022 - 01/2002
9	Proteins (Proteins, Gene)FDA Link 04/2016 - 06/2003
9	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 02/2002
8	Pharmaceutical PreparationsIBA 01/2019 - 05/2005
6	Dacarbazine (DIC)FDA LinkGeneric 03/2015 - 04/2004
5	pembrolizumabIBA 01/2022 - 01/2017
4	Interferon-alpha (Interferon Alfa)IBA 01/2022 - 01/2003
4	AntibodiesIBA 01/2021 - 06/2013
4	Interferon alpha-2 (Roferon-A)FDA Link 01/2020 - 03/2002
4	LigandsIBA 03/2015 - 12/2008
4	Phosphotransferases (Kinase)IBA 12/2014 - 04/2004
4	MelacineIBA 10/2014 - 04/2002
4	Histocompatibility Antigens Class IIBA 10/2014 - 04/2002
4	Cancer VaccinesIBA 06/2003 - 01/2002
4	Peptides (Polypeptides)IBA 06/2003 - 01/2002
3	Immune Checkpoint InhibitorsIBA 01/2022 - 10/2019
3	InterleukinsIBA 01/2022 - 12/2008
3	Messenger RNA (mRNA)IBA 10/2019 - 08/2013
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2017 - 09/2004
3	Cisplatin (Platino)FDA LinkGeneric 11/2014 - 04/2004
3	ORALIT (ORS)IBA 05/2014 - 08/2012
3	Mitogen-Activated Protein KinasesIBA 01/2014 - 01/2012
3	Hematoxylin (Haematoxylon)IBA 10/2010 - 05/2002
3	Eosine Yellowish-(YS) (Eosin)IBA 10/2010 - 05/2002
3	Imatinib Mesylate (Gleevec)FDA Link 10/2010 - 01/2008
3	HLA Antigens (Human Leukocyte Antigens)IBA 09/2010 - 10/2002
2	Small Cytoplasmic RNAIBA 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Viral DNAIBA 01/2021 - 01/2021
2	dabrafenibIBA 11/2020 - 12/2016
2	NivolumabIBA 11/2020 - 01/2017
2	trametinibIBA 11/2020 - 01/2018
2	Keratins (Keratin)IBA 01/2020 - 05/2003
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2014 - 01/2005
2	Vinblastine (Vinblastine Sulfate)FDA Link 11/2014 - 12/2008
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 10/2014 - 04/2002
2	tyrosine receptor (receptor, tyrosine)IBA 07/2014 - 02/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2014 - 01/2012
2	Carboplatin (JM8)FDA LinkGeneric 05/2014 - 01/2012
2	Biological ProductsIBA 11/2013 - 01/2011
2	Type 1 Melanocortin ReceptorIBA 08/2013 - 12/2012
2	Small Interfering RNA (siRNA)IBA 06/2013 - 04/2011
2	ErbB Receptors (EGF Receptor)IBA 05/2013 - 02/2005
2	Coloring Agents (Dyes)IBA 02/2013 - 01/2013
2	Sorafenib (BAY 43-9006)FDA Link 02/2012 - 01/2012
2	Thalidomide (Thalomid)FDA Link 01/2010 - 11/2007
2	Indicators and Reagents (Reagents)IBA 07/2009 - 02/2008
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2008 - 01/2003
2	Protein Subunit VaccinesIBA 01/2003 - 01/2002
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	binimetinibIBA 11/2020
1	cobimetinibIBA 11/2020
1	encorafenibIBA 11/2020
1	MucinsIBA 01/2020
1	CholesterolIBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 06/2019

Therapy/Procedure

82	Therapeutics 09/2022 - 01/2002
27	Immunotherapy 01/2022 - 01/2002
20	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2003
16	Drug Therapy (Chemotherapy) 01/2018 - 02/2002
11	Radiotherapy 07/2021 - 09/2007
5	Neoadjuvant Therapy 08/2022 - 01/2017
5	Chemoprevention 01/2019 - 03/2005
2	Adjuvant Radiotherapy 06/2020 - 05/2014
2	Biological Therapy 11/2014 - 05/2011
2	Palliative Care (Palliative Therapy) 01/2010 - 07/2007
1	Ultrasonic Surgical Procedures 01/2021